Neurofilament light‐chain response during therapy with antisense oligonucleotide tofersen in SOD1‐related ALS: Treatment experience in clinical practice

Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study

(2022) Thomas Meyer et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

(2022) Timothy M. Miller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen

(2021) Thomas Meyer et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model

(2021) Marie Dreger et al.   Frontiers in Neuroscience

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

(2020) Michael Benatar et al.   NEUROLOGY

The Beginning of Genomic Therapies for ALS

(2020) Orla Hardiman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

(2020) Timothy Miller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis

(2019) E. Thouvenot et al.   EUROPEAN JOURNAL OF NEUROLOGY

Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models

(2018) Alex McCampbell et al.   JOURNAL OF CLINICAL INVESTIGATION

Comprehensive analysis of the mutation spectrum in 301 German ALS families

(2018) Kathrin Müller et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

(2017) Emily Feneberg et al.   NEUROLOGY

SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology

(2014) Rosie K. A. Bunton-Stasyshyn et al.   NEUROSCIENTIST

Measuring function in advanced ALS: validation of ALSFRS-EX extension items

(2009) P. Wicks et al.   EUROPEAN JOURNAL OF NEUROLOGY